Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2014. Start Trial.
Date Value
October 23, 2026 8.372
October 22, 2026 8.366
October 21, 2026 8.557
October 20, 2026 8.371
October 19, 2026 8.114
October 16, 2026 7.742
October 15, 2026 8.065
October 14, 2026 7.825
October 13, 2026 7.915
October 12, 2026 7.635
October 09, 2026 7.702
October 08, 2026 7.525
October 07, 2026 7.626
October 06, 2026 7.716
October 05, 2026 8.449
October 02, 2026 8.123
October 01, 2026 8.012
September 30, 2026 7.863
September 29, 2026 7.744
September 28, 2026 7.814
September 25, 2026 7.703
September 24, 2026 7.424
September 23, 2026 6.570
September 22, 2026 6.833
September 21, 2026 6.572
Date Value
September 18, 2026 6.512
September 17, 2026 6.566
September 16, 2026 6.478
September 15, 2026 6.368
September 14, 2026 6.335
September 11, 2026 6.080
September 10, 2026 6.051
September 09, 2026 6.052
September 08, 2026 6.086
September 04, 2026 6.155
September 03, 2026 6.031
September 02, 2026 6.000
September 01, 2026 5.924
August 31, 2026 6.062
August 28, 2026 6.023
August 27, 2026 6.334
August 26, 2026 6.164
August 25, 2026 6.145
August 24, 2026 5.746
August 21, 2026 5.880
August 20, 2026 5.684
August 19, 2026 5.626
August 18, 2026 5.586
August 17, 2026 5.610
August 14, 2026 5.482

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Natera, Inc. 31.85
Caris Life Sciences, Inc. 15.28
Myriad Genetics, Inc. 1.831
BioRestorative Therapies, Inc. 0.6821
Exagen, Inc. 14.40

Price to Book Value Related Metrics